Expression, localization and functional role of small GTPases of the Rab3 family in insulin-secreting cells

1996 ◽  
Vol 109 (9) ◽  
pp. 2265-2273 ◽  
Author(s):  
R. Regazzi ◽  
M. Ravazzola ◽  
M. Iezzi ◽  
J. Lang ◽  
A. Zahraoui ◽  
...  

We examined the presence of small molecular mass GTP-binding proteins of the Rab3 family in different insulin-secreting cells. Rab3B and Rab3C were identified by western blotting in rat and in human pancreatic islets, in two rat insulin-secreting cell lines, RINm5F and INS-1, as well as in the hamster cell line HIT-T15. In contrast, Rab3A was detected in rat pancreatic islets as well as in the two insulin-secreting rat cell lines but not in human pancreatic islets and was only barely discernible in HIT-T15 cells. These findings were confirmed by two-dimensional gel electrophoresis followed by GTP-overlay of homogenates of pancreatic islets and of the purified protein. Northern blotting analysis revealed that Rab3D is expressed in the same insulin-secreting cells as Rab3A. Separation of the cells of the rat islets by fluorescence-activated cell sorting demonstrated that Rab3A was exclusively expressed in beta-cells. Rab3A was found to be associated with insulin-containing secretory granules both by immunofluorescence, immunoelectron microscopy and after sucrose density gradient. Overexpression in HIT-T15 cells of a Rab3A mutant deficient in GTP hydrolysis inhibited insulin secretion stimulated by a mixture of nutrients and bombesin. Insulin release triggered by these secretagogues was also slightly decreased by the overexpression of wild-type Rab3A but not by the overexpression of wild-type Rab5A and of a Rab5A mutant deficient in GTP hydrolysis. Finally, we studied the expression in insulin-secreting cells of rabphilin-3A, a putative effector protein that associates with the GTP-bound form of Rab3A. This Rab3A effector was not detectable in any of the cells investigated in the present study. Taken together these results indicate an involvement of Rab3A in the control of insulin release in rat and hamster. In human beta-cells, a different Rab3 isoform but with homologous function may replace Rab3A.

1987 ◽  
Vol 35 (10) ◽  
pp. 1059-1062
Author(s):  
A Haddad ◽  
B Kopriwa ◽  
G Pelletier

To determine whether or not the secretory granules of insulin-secreting cells contained glycoproteins, isolated rat pancreatic islets were incubated for 2 and 4 hr in a medium containing L-[3H]-fucose. Quantitative analysis of high-resolution electron microscopic autoradiographs of the insulin-secreting beta cells demonstrated that glycoproteins with fucose residues are contained within the insulin secretory granule.


1997 ◽  
Vol 34 (1) ◽  
pp. 46-48 ◽  
Author(s):  
R. Lupi ◽  
P. Marchetti ◽  
R. Giannarelli ◽  
A. Coppelli ◽  
C. Tellini ◽  
...  

1997 ◽  
Vol 82 (8) ◽  
pp. 2660-2663
Author(s):  
Décio L. Eizirik ◽  
Leif Jansson ◽  
Malin Flodström ◽  
Claes Hellerström ◽  
Arne Andersson

Pancreas ◽  
2001 ◽  
Vol 22 (1) ◽  
pp. 69-71 ◽  
Author(s):  
Josepha Fernandez-Alvarez ◽  
Dominique Hillaire-Buys ◽  
Marie-Madeleine Loubati??res-Mariani ◽  
Ramon Gomis ◽  
Pierre Petit

PLoS ONE ◽  
2013 ◽  
Vol 8 (1) ◽  
pp. e55064 ◽  
Author(s):  
Dagmar Klein ◽  
Ryosuke Misawa ◽  
Valia Bravo-Egana ◽  
Nancy Vargas ◽  
Samuel Rosero ◽  
...  

Diabetologia ◽  
2010 ◽  
Vol 53 (7) ◽  
pp. 1395-1405 ◽  
Author(s):  
M. Igoillo-Esteve ◽  
L. Marselli ◽  
D. A. Cunha ◽  
L. Ladrière ◽  
F. Ortis ◽  
...  

2019 ◽  
Vol 62 (4) ◽  
pp. 159-168
Author(s):  
Z Ma ◽  
D F J Ketelhuth ◽  
T Wirström ◽  
T Ohki ◽  
M J Forteza ◽  
...  

Modified lipoproteins can negatively affect beta cell function and survival. However, the mechanisms behind interactions of modified lipoproteins with beta cells – and in particular, relationships to increased uptake – are only partly clarified. By over-expressing the scavenger receptor CD36 (Tet-on), we increased the uptake of fluorescent low-density modified lipoprotein (oxLDL) into insulin-secreting INS-1 cells. The magnitude of uptake followed the degree of CD36 over-expression. CD36 over-expression increased concomitant efflux of3H-cholesterol in proportion to the cellular contents of3H-cholesterol. Exposure to concentrations of oxLDL from 20 to 100 µg/mL dose-dependently increased toxicity (evaluated by MTT) as well as apoptosis. However, the increased uptake of oxLDL due to CD36 over-expression did not exert additive effects on oxLDL toxicity – neither on viability, nor on glucose-induced insulin release and cellular content. Reciprocally, blocking CD36 receptors by Sulfo-N-Succinimidyl Oleate decreased the uptake of oxLDL but did not diminish the toxicity. Pancreatic islets of CD36−/−mice displayed reduced uptake of3H-cholesterol-labeled oxLDL vs wild type but similar toxicity to oxLDL. OxLDL was found to increase the expression of CD36 in islets and INS-1 cells. In summary, given the experimental conditions, our results indicate that (1) increased uptake of oxLDL is not responsible for toxicity of oxLDL, (2) increased efflux of the cholesterol moiety of oxLDL counterbalances, at least in part, increased uptake and (3) oxLDL participates in the regulation of CD36 in pancreatic islets and in INS-1 cells.


2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Vijayalakshmi Deivasikamani ◽  
Savitha Dhayalan ◽  
Yilizila Abudushalamu ◽  
Romana Mughal ◽  
Asjad Visnagri ◽  
...  

AbstractGlucose and hypotonicity induced cell swelling stimulate insulin release from pancreatic β-cells but the mechanisms are poorly understood. Recently, Piezo1 was identified as a mechanically-activated nonselective Ca2+ permeable cationic channel in a range of mammalian cells. As cell swelling induced insulin release could be through stimulation of Ca2+ permeable stretch activated channels, we hypothesised a role for Piezo1 in cell swelling induced insulin release. Two rat β-cell lines (INS-1 and BRIN-BD11) and freshly-isolated mouse pancreatic islets were studied. Intracellular Ca2+ measurements were performed using the fura-2 Ca2+ indicator dye and ionic current was recorded by whole cell patch-clamp. Piezo1 agonist Yoda1, a competitive antagonist of Yoda1 (Dooku1) and an inactive analogue of Yoda1 (2e) were used as chemical probes. Piezo1 mRNA and insulin secretion were measured by RT-PCR and ELISA respectively. Piezo1 mRNA was detected in both β-cell lines and mouse islets. Yoda1 evoked Ca2+ entry was inhibited by Yoda1 antagonist Dooku1 as well as other Piezo1 inhibitors gadolinium and ruthenium red, and not mimicked by 2e. Yoda1, but not 2e, stimulated Dooku1-sensitive insulin release from β-cells and pancreatic islets. Hypotonicity and high glucose increased intracellular Ca2+ and enhanced Yoda1 Ca2+ influx responses. Yoda1 and hypotonicity induced insulin release were significantly inhibited by Piezo1 specific siRNA. Pancreatic islets from mice with haploinsufficiency of Piezo1 released less insulin upon exposure to Yoda1. The data show that Piezo1 channel agonist induces insulin release from β-cell lines and mouse pancreatic islets suggesting a role for Piezo1 in cell swelling induced insulin release. Hence Piezo1 agonists have the potential to be used as enhancers of insulin release.


Diabetes ◽  
2001 ◽  
Vol 50 (5) ◽  
pp. 985-991 ◽  
Author(s):  
A. Antonelli ◽  
G. Baj ◽  
P. Marchetti ◽  
P. Fallahi ◽  
N. Surico ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document